Vaccines in Breast Cancer: Challenges and Breakthroughs
- PMID: 37443570
- PMCID: PMC10340541
- DOI: 10.3390/diagnostics13132175
Vaccines in Breast Cancer: Challenges and Breakthroughs
Abstract
Breast cancer is a problem for women's health globally. Early detection techniques come in a variety of forms ranging from local to systemic and from non-invasive to invasive. The treatment of cancer has always been challenging despite the availability of a wide range of therapeutics. This is either due to the variable behaviour and heterogeneity of the proliferating cells and/or the individual's response towards the treatment applied. However, advancements in cancer biology and scientific technology have changed the course of the cancer treatment approach. This current review briefly encompasses the diagnostics, the latest and most recent breakthrough strategies and challenges, and the limitations in fighting breast cancer, emphasising the development of breast cancer vaccines. It also includes the filed/granted patents referring to the same aspects.
Keywords: adjuvants; antigens; biomarkers; breast cancer; challenges; diagnostics; patents; therapeutics; vaccine strategies.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.Drugs R D. 2005;6(3):178-85. doi: 10.2165/00126839-200506030-00007. Drugs R D. 2005. PMID: 15869322 Review.
-
Cancer vaccine THERATOPE- Biomira.Drugs R D. 2003;4(4):236-40. doi: 10.2165/00126839-200304040-00004. Drugs R D. 2003. PMID: 12848588
-
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.Breast Cancer (Auckl). 2015 Sep 27;9(Suppl 2):17-34. doi: 10.4137/BCBCR.S29420. eCollection 2015. Breast Cancer (Auckl). 2015. PMID: 26462242 Free PMC article. Review.
-
KRAS Pathways: A Potential Gateway for Cancer Therapeutics and Diagnostics.Recent Pat Anticancer Drug Discov. 2024;19(3):268-279. doi: 10.2174/1574892818666230406085120. Recent Pat Anticancer Drug Discov. 2024. PMID: 37038676 Review.
-
A patent perspective on chikungunya.Acta Trop. 2019 Nov;199:105131. doi: 10.1016/j.actatropica.2019.105131. Epub 2019 Aug 8. Acta Trop. 2019. PMID: 31401192 Review.
Cited by
-
Recent Advances in Immunotherapy for Breast Cancer: A Review.Breast Cancer (Dove Med Press). 2024 Aug 27;16:497-516. doi: 10.2147/BCTT.S482504. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39220564 Free PMC article. Review.
-
Advances in Amino Acid-Based Chemistry.Pharmaceuticals (Basel). 2023 Oct 19;16(10):1490. doi: 10.3390/ph16101490. Pharmaceuticals (Basel). 2023. PMID: 37895960 Free PMC article.
-
Nanoparticle-Based Antioxidants in Stress Signaling and Programmed Cell Death in Breast Cancer Treatment.Molecules. 2023 Jul 10;28(14):5305. doi: 10.3390/molecules28145305. Molecules. 2023. PMID: 37513179 Free PMC article. Review.
References
-
- Hylton N.M., Gatsonis C.A., Rosen M.A., Lehman C.D., Newitt D.C., Partridge S.C., Bernreuter W.K., Pisano E.D., Morris E.A., Weatherall P.T., et al. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by Mr Imaging Predicts Recurrence-Free Survival-Results from the Acrin 6657/Calgb 150007 I-Spy 1 Trial. Radiology. 2016;279:44–55. doi: 10.1148/radiol.2015150013. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources